期刊文献+

泰拉霉素的合成工艺研究 被引量:2

Study on the synthesis of Tulathromycin
下载PDF
导出
摘要 以二氢高红霉素(去甲基阿奇霉素)为原料,经CbzCl保护、Swern氧化、环氧化、烯丙基胺开环氧和钯碳催化加氢五步反应以46%的总收率合成了泰拉霉素(纯度97%),其结构经液相色谱与标准品对比确认。烯丙基胺乙醇溶液开环氧与催化加氢两步反应实现一锅法,简化了工艺操作,降低了分离难度,加之采用钠氢作无机碱和TFA成盐条件,减少了副反应的发生,提高了收率和产品纯度。 By using dihydroerythromycin (demethylazithromycin) as initial material, undergoes five step reactions: CbzC1 protection, Swern oxidation, epoxidation, opening the epoxide by allylamine, catalytic hy- drogenation by palladium carbon,Tulathromycin was synthesized in 46% total yield and 97% purity. The structure was confirmed by liquid chromatography with .standard contrast. The allylamine' s ethanol solu- tion to open the epoxy and catalytic hydrogenation two-step reactions were featured with one-pot reaction leads to simplify the process operation and reduce the difficulty of separation, which combined with sodi- um hydrogen as inorganic base and TFA salt conditions reduced side reactions, improved the yield and product purity
作者 王伟 陈锦春
出处 《应用化工》 CAS CSCD 2012年第7期1294-1296,共3页 Applied Chemical Industry
基金 烟台大学博士科研启动基金项目(HY07B30)
关键词 泰拉霉素 去甲基阿奇霉素 烯丙基胺 合成 Tulathromycin dihydroerythromycin allylamine synthesis
  • 相关文献

参考文献10

二级参考文献45

  • 1李玮,郭腾,陈洪亮,禚宝山.兽用新型大环内酯类抗生素——土拉霉素(ulathromycin)[J].中国动物保健,2006,8(4):38-39. 被引量:7
  • 2宋福杰,刘明春,邹美,符特.兽用抗菌药物土拉霉素研究进展[J].兽药与饲料添加剂,2006,11(4):4-6. 被引量:8
  • 3Godinho K S,Keane S G,Nanjiani I A,et al. Minimum Inhibitory Concentrations of Tulathromycin against Respiratory Bacterial Pathogens Isolated from Clinical Cases in European Cattle and Swine and Variability Arising from Chang.es in vitro Methodology [J]. Vet Ther,2005,6(2) :113 -121.
  • 4Reese C P,Norcia L J ,Skogerboe T L,et al. Time - killing Kinetics and Impact of Culture Conditions (pH , CO2 and serum) om MIC Values of Tulathromycin against Hameophilus Sonmus [ D ]. Proc 23rd World Buiatries Congr,2004:70 -71.
  • 5Nowakowski M A,Inskeep P B, Risk J E,et al. Pharmacokinetics and Lung Tissue Concentrations of Tulathromycin, a New Triamilide Antibiotic in Cattle[ J]. Vet Ther,2004, 5 (1) :60 - 74.
  • 6Benchaoui H A, Nowakowski M, Sherington J ,et al. Pharmacokinetics and Lung Tissue Concentrations of Tulathromycin in Swine [J]. Vet Pharmaeol Ther,2004,27(4) :203 -210.
  • 7Eberhard Scheuch A, Janina Spieker A, Monica Venner B, et al. Quantitative Determination of the Macrolide Antibiotic Tulathromycin in Plasma and Broncho - alveolar Cells of Foals Using Tandem Mass Spectrometry [ J].Journal of Chromatography B, 2007,850 : 464 - 470.
  • 8Nutsch R G, Hart F J, Rooney K A,et al. Efficacy of Tulathromycin Injectable Solution for the Treatment of Naturally Occurring Swine Respiratory Disease [ J ]. Vet Ther, 2005,6 ( 2 ) : 214 - 224.
  • 9McKelvie J,Morgan J H,Nanjiani I A,et al. Evaluation of Tulathromycin for the Treatment of Pneumonia Following Experimental Infection of Swine with Mycoplasma Hyopneumoniae [ J ]. Vet Ther,2005,6( 2 ) : 197 - 202.
  • 10Skogerboe T L, Rooney K A, Nutsch R G, et al. Comparative Efficacy of Tulathromycin Versus Florfenicol and Tilmicosin against Undifferentiated Bovine Respiratory Disease in Feedlot Cattle[ J]. Vet Ther,2005,6(2) : 180 - 196.

共引文献22

同被引文献12

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部